StayWell

Yardley,  PA 
United States
http://www.staywell.com
  • Booth: 3443

StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell is majority-owned by HSS, LLC, a wholly owned subsidiary of Merck & Co., Inc..


 Press Releases

  • YARDLEY, PA (Feb. 17, 2017)StayWell will take visitors on a journey through its leading-edge consumer engagement and digital marketing technology solutions at the HiMSS 2017 conference, Feb. 19-23 in Orlando, FL.

    StayWell will conduct product demonstrations that explore technology solutions built to help hospitals and health systems manage the health of populations, improve patient outcomes across the care continuum, and engage current and prospective patients with hospital and health system brands.

    StayWell’s clinical interactive and mobile patient engagement solutions allow providers to more easily share information with patients, creating a more cohesive patient experience and increasing adherence to care plans. The EHR interoperability facilitated by StayWell solutions drives patient engagement and can improve patient safety and outcomes.

    All visitors to the StayWell booth will receive a passport that will be stamped for each demonstration they attend at booth 3443. Passports will be entered for prize drawings.

    INTERVIEW AND MEDIA OPPORTUNITIES

    Location:                   Booth 3443 in the Orange County Convention Center

    Presentations: 

    • Patient-Centered Security Architecture: The Key to Personal Health Information (11:30 a.m. Monday, 3:30 p.m. Tuesday and 10:30 a.m. Wednesday)
    • Mobile-Driven Patient Engagement: Next-Generation Patient-Centered Disease Management (12 p.m. Monday and 1 p.m. Tuesday)
    • ILÚM and MedHelp (12:30 p.m. Monday, 11 a.m. Tuesday, and 2 p.m. Wednesday)
    • It’s Not About You: Using Patient Stories to Transform Health Care (2:30 p.m. Monday)
    • Interoperable Patient Education: Serving Patients Along the Care Continuum (3 p.m. Monday and 10 a.m. Wednesday)
    • Providing a Consistent Patient Experience With SMART on FHIR (3:30 p.m. Monday, 11:30 a.m. Tuesday and 2:30 p.m. Wednesday)
    • Beyond a Prescription: Enhancing Medication Info Online and On the Go (4:30 p.m. Monday, 10:30 a.m. Tuesday and 11:30 a.m. Wednesday)
    • Improving Patient Engagement Through Storytelling (10 a.m. Tuesday)
    • Infobutton, Blue Button, and Open Notes, Oh My!: Driving Toward Patient Engagement (12 p.m. Tuesday, and 3 p.m. Wednesday)
    • First Comes Marriage, Then Comes Engagement: The Union of Content and Technology (2:30 p.m. Tuesday)
    • What’s an Explainer To Do? Explaining Complex Subjects With Consumable, Fun, and Compelling Videos (12 p.m. Wednesday)
    • What Do the New Provisions In the Affordable Care Act Mean to You? (1 p.m. Wednesday)

    Interviews:                 To schedule a one-on-one media briefing with StayWell during or after HiMSS, contact Barbara Tabor at (651) 230-9192.

    ###

    About StayWell

    StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, Pennsylvania, and also has major locations in Salt Lake City, Utah, and St. Paul, Minn. To learn more, visit http://www.staywell.com.

    About Merck

    For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on TwitterFacebookYouTube and LinkedIn.

    Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

    This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

    Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

    The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

    Media contact

    Barbara Tabor, APR / 651-230-9192 / barbara@taborPR.com

  • Yardley, PA (February 20, 2017)The StayWell Company and VUCA Health announced today that they are collaborating to help health care providers better manage patient health risks, foster behavior change and improve health literacy among patients. VUCA Health, which created and manages the largest medication video library in the world, will present a demonstration of its video capability at StayWell booth 3443 during HiMSS.

    The VUCA library has approximately 500 unique medication videos, over 60 administration technique videos (e.g. insulin injection, inhaler use, patches), and more than 80 condition-specific videos. In total, VUCA content covers over 85 percent of all medications dispensed. 

    The average video is about 60 seconds long and is designed to help patients understand their prescription medications in a more digestible, digital format. VUCA videos cover medication names, indications, side effects and potential interactions. All videos are available in English and Spanish.

    According to Joni Pierce, senior vice president of product management and innovation at StayWell, the arrangement strengthens StayWell’s commitment to empowering patients to take an active role in managing their health with a wide range of credible, patient education content.

    “We’re motivated by knowing that our patient education solutions affect real people and can help them navigate a sometimes challenging, and often confusing, health journey,” said Pierce.  “VUCA Health videos support StayWell’s efforts to improve patient outcomes and satisfaction — even after they’ve left the doctor’s office.”

    According to David Medvedeff, chief executive officer of VUCA Health, the name VUCA refers to “volatility, uncertainty, complexity and ambiguity” that can be created during military engagements and strategic business planning. This concept is all too often associated with health care situations for patients.

    “At VUCA, our mission is to resolve the complexity and ambiguity for today’s patients, and instead bring vision, understanding, clarity and action to their journey and the health care industry,” said Medvedeff. “We’re excited to partner with StayWell to expand our mission and reach.”

    To learn more about StayWell patient education and engagement solutions, including its collaboration with VUCA Health, visit StayWell at HIMSS booth 3443 on Monday, February 20, at 4:30 p.m., EST for the presentation entitled, Beyond a Prescription: Enhancing Medication Information Online and On-the-Go.”

    ###

    About StayWell

    StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, Pennsylvania, and also has major locations in Salt Lake City, Utah, and St. Paul, Minn. To learn more, visit http://www.staywell.com.

    About Merck

    For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on TwitterFacebookYouTube and LinkedIn.

    Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

    This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

    Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

    The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

    About VUCA Health
    VUCA Health was founded by experts within the pharmacy practice, clinical publishing and technology industries with decades of experience in retail pharmacy, drug reference, clinical content, e-prescribing and database development. By resolving the challenges inherent in healthcare’s ongoing evolution, VUCA Health brings vision, understanding, clarity and action to the healthcare industry today.

    Media contact

    Barbara Tabor, APR / 651-230-9192 / barbara@taborPR.com
  • Yardley, PA (February 21, 2017) – The StayWell Company announced today that Krames CareEngageTM powered by Doctella now features a SMART on FHIR application. The SMART on FHIR application is available for testing with clients who use CareEngage for patient education and care management. StayWell will demonstrate the CareEngage solution during #HiMSS17 at booth 3443.

    CareEngage is an interactive platform that addresses real-world health needs, such as patient compliance and chronic conditions, by keeping patients better informed and engaged in their care. The platform is licensed by hospitals and health systems and can be integrated into EHR systems to improve patient safety, quality and compliance. SMART (Substitutable Medical Applications and Reusable Technologies) on FHIR (Fast Health Interoperability Resources) is a fast-growing and much-lauded technology that facilitates the connection of EHRs across health care provider organizations and allows patient education to be prescribed from, and tracked in the EHR.

    Effectively engaging patients and caregivers is essential to hospitals and health systems in new value-based payment models, because engagement — which can be fostered by interactive education, communications and positive feedback — can contribute to improved patient compliance and clinical outcomes under MACRA and MIPS.

    Earlier this month, early adopters of CareEngage met to discuss implementation strategies and use of the platform within their hospital business units and outlined targeted departments, processes and workflows that could be improved by CareEngage. These early adopters are part of the Krames CareEngage Collaborative, which will also assist in tracking metrics to measure platform usage and satisfaction.

    “Health care regulations are putting an increased focus on patient-centered and value-based care. Giving patients anytime-access to their health information and fostering communication between health care providers, patients and their families, encourages people to take a more active role in their care. In the long run, this will lead to better health and a more satisfying care journey for patients, and improved quality, safety and reimbursement for hospitals,” said Nicole Latimer, president, StayWell.

    CareEngage augments verbal instructions and print materials with state-of-the-art, customizable and interactive, multimedia tools that can be easily shared with family and caregivers.

    It is a unique application of quality improvement science and physician-developed Smartlists delivered in an open, interactive content framework that maps the complete patient journey, including: patient preferences, education, care instructions, symptom tracking, beliefs, belonging, insights and patient reported outcomes and measures. The addition of SMART on FHIR to the CareEngage solution will make the integration and use of the platform across provider locations efficient for both clinicians and patients.

    “SMART on FHIR is emerging as the new industry standard for patient-facing health technology solutions. It neutralizes potential issues related to platform compatibility across health systems and creates a user-friendly, seamless environment for patients and health care professionals,” said Amer Haider, CEO of Doctella. “The potential that this delivers to health systems across the country who use CareEngage is significant and timely to the pressing needs of our health care marketplace.”

    Existing StayWell customers can easily integrate CareEngage into their EHR workflow using the SMART on FHIR application.

    To learn more about CareEngage or to join the Krames CareEngage Collaborative, a cohort of early adopters established by StayWell, visit www.staywell.com/doctella.

    Follow and participate in the conversation on Twitter: #StayWellCareEngage #MedicalErrors #PatientSafety #PatientEngagement #Checklists #DoctellaChecklists #DigitalHealth #HealthApp #SMARTonFHIR #HIMSS17

    About StayWell

    StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, Pennsylvania, and also has major locations in Salt Lake City, Utah, and St. Paul, Minn. To learn more, visit http://www.staywell.com.

    About Merck

    For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on TwitterFacebookYouTube and LinkedIn.

    Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

    This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

    Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

    The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

    About Doctella:

    Doctella.com, by Patient Doctor Technologies, Inc. and creators of Doctella Smartlist technology, is based in Silicon Valley. The company provides a comprehensive patient-centered outcomes management platform to improve the culture, communication, and engagement between patients, families, and providers. The Doctella Smartlist app was developed by leading researchers from Johns Hopkins and at other leading institutions. The StayWell Company, LLC, is an investor in Doctella. Start your journey to better, safer care at http://www.doctella.com

    Media contact

    Barbara Tabor, APR / 651-230-9192 / barbara@taborPR.com

 For technical assistance with this webpage please: Click Here For all other inquiries, please contact show management.